 SANTA CLARA, Calif., Aug. 09, 2021 GLOBE NEWSWIRE -- Shockwave Medical, Inc. Nasdaq: SWAV, a pioneer in the development and commercialization of Intravascular Lithotripsy IVL to treat complex calcified cardiovascular disease, today reported financial results for the three months ended June 30, 2021. 